NCT03825861View on ClinicalTrials.gov

Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 23, 2017

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Gastric Cancer
Interventions
DRUG

FOLFIRINOX

Oxaliplatin 85mg/m2, Leucovorin 200mg/m2, Irinotecan 180mg/m2, 5-FU 400mg/m2 bolus followed by 2400mg/m2 continuous infusion.

Trial Locations (1)

01246-000

RECRUITING

Instituto do Câncer do Estado de São Paulo, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER